BE898417A - Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. - Google Patents
Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. Download PDFInfo
- Publication number
- BE898417A BE898417A BE0/212016A BE212016A BE898417A BE 898417 A BE898417 A BE 898417A BE 0/212016 A BE0/212016 A BE 0/212016A BE 212016 A BE212016 A BE 212016A BE 898417 A BE898417 A BE 898417A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- weight
- hydrocortisone
- solution
- composition according
- Prior art date
Links
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 229960000890 hydrocortisone Drugs 0.000 title claims abstract description 31
- 239000000243 solution Substances 0.000 claims abstract description 18
- 239000003246 corticosteroid Substances 0.000 claims abstract description 11
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 8
- -1 2-isostearyl 1-hydroxyethyl Chemical group 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 229920000223 polyglycerol Polymers 0.000 claims description 4
- FYUHFVHZYOANMN-UHFFFAOYSA-M [Cl-].C(CCCCCCCCCCCCCCC(C)C)CC(O)[N+]1(C=NCC1)CC1=CC=CC=C1 Chemical compound [Cl-].C(CCCCCCCCCCCCCCC(C)C)CC(O)[N+]1(C=NCC1)CC1=CC=CC=C1 FYUHFVHZYOANMN-UHFFFAOYSA-M 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000002453 shampoo Substances 0.000 claims description 3
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 claims description 2
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 claims description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 230000035515 penetration Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- BCFKVTZTWPPNNZ-UHFFFAOYSA-N 1-benzyl-4,5-dihydroimidazole Chemical compound C=1C=CC=CC=1CN1CCN=C1 BCFKVTZTWPPNNZ-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- YDLSUFFXJYEVHW-UHFFFAOYSA-N azonan-2-one Chemical compound O=C1CCCCCCCN1 YDLSUFFXJYEVHW-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU84514A LU84514A1 (fr) | 1982-12-09 | 1982-12-09 | Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE898417A true BE898417A (fr) | 1984-06-08 |
Family
ID=19729991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/212016A BE898417A (fr) | 1982-12-09 | 1983-12-08 | Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS59112921A (enrdf_load_stackoverflow) |
| BE (1) | BE898417A (enrdf_load_stackoverflow) |
| CH (1) | CH658191A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3344437A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2537438B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2131693B (enrdf_load_stackoverflow) |
| LU (1) | LU84514A1 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1223343B (it) * | 1987-11-03 | 1990-09-19 | Also Lab Sas | Formulazioni farmaceutiche per somministrazione transdermica |
| EP0978574A1 (en) * | 1998-08-04 | 2000-02-09 | Nalco Chemical Company | Compositions of cationic surfactants and their use as antifouling agents for induced draft fans (IDF) |
| US20060018852A1 (en) | 2003-08-22 | 2006-01-26 | L'oreal | Compositions containing topical active agents and pentylene glycol |
| US10851507B2 (en) | 2017-12-11 | 2020-12-01 | Pro-Tech Manufacturing And Distribution, Inc. | Material pusher with floating coupler |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE673500C (de) * | 1933-01-15 | 1939-03-23 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung von haltbaren Loesungen schwer loeslicher Arzneimittel |
| NL6610468A (enrdf_load_stackoverflow) * | 1965-08-03 | 1967-02-06 | ||
| FR2314731A1 (fr) * | 1975-06-19 | 1977-01-14 | Nelson Res & Dev | Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients |
| US4082881A (en) * | 1976-12-23 | 1978-04-04 | E. R. Squibb & Sons, Inc. | Topical and other type pharmaceutical formulations containing isosorbide carrier |
| SE8004580L (sv) * | 1980-06-19 | 1981-12-20 | Draco Ab | Farmaceutisk beredning |
-
1982
- 1982-12-09 LU LU84514A patent/LU84514A1/fr unknown
-
1983
- 1983-12-08 GB GB08332805A patent/GB2131693B/en not_active Expired
- 1983-12-08 CH CH6582/83A patent/CH658191A5/fr not_active IP Right Cessation
- 1983-12-08 FR FR8319664A patent/FR2537438B1/fr not_active Expired
- 1983-12-08 DE DE19833344437 patent/DE3344437A1/de active Granted
- 1983-12-08 JP JP58230726A patent/JPS59112921A/ja active Granted
- 1983-12-08 BE BE0/212016A patent/BE898417A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2537438A1 (fr) | 1984-06-15 |
| DE3344437C2 (enrdf_load_stackoverflow) | 1991-04-04 |
| GB2131693B (en) | 1986-07-02 |
| GB2131693A (en) | 1984-06-27 |
| LU84514A1 (fr) | 1984-10-22 |
| DE3344437A1 (de) | 1984-06-14 |
| JPH034044B2 (enrdf_load_stackoverflow) | 1991-01-22 |
| FR2537438B1 (fr) | 1985-11-22 |
| CH658191A5 (fr) | 1986-10-31 |
| GB8332805D0 (en) | 1984-01-18 |
| JPS59112921A (ja) | 1984-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH657987A5 (fr) | Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un autre principe actif. | |
| EP0680745B1 (fr) | Utilisation de composés antifongiques et de composés antibactériens halogénés pour diminuer la chute des cheveux | |
| EP0971687B1 (fr) | Solutions aqueuses de derives d'acide salicylique | |
| CH656532A5 (fr) | Composition stable pour corticotherapie locale. | |
| CA1302286C (fr) | Composition cosmetique detergente et moussante, retardant le regraissage des cheveux | |
| CA1341273C (fr) | Systeme anti-oxydant a base d'un ester d'ascorbyle stabilise et compositions contenant un tel systeme anti-oxydant | |
| LU85111A1 (fr) | Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire | |
| FR2743813A1 (fr) | Composition gelifiee stable a forte teneur en electrolyte | |
| FR2577805A1 (fr) | Composition de traitement de la peau a base de glucoside d'hydroquinone | |
| WO1997003638A1 (fr) | Composition capillaire a base de minoxidil a faible teneur en solvant gras | |
| WO2007132134A2 (fr) | Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations | |
| EP0835652B1 (fr) | Utilisation d'au moins un glycol comme agent de solubilisation de la mélatonine dans l'eau et compositions les contenant | |
| FR2490492A1 (fr) | Composition cosmetique pour le traitement local de la cellulite | |
| BE898417A (fr) | Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. | |
| EP2114387B1 (fr) | Utilisation de compositions comprenant au moins une lignane et/ou neolignane pour moduler le taux de testosterone | |
| FR2855721A1 (fr) | Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique | |
| EP0243248A1 (fr) | Compositions pour le traitement de la calvitie et des alopécies | |
| EP0751759B1 (fr) | Lotion capillaire a base de minoxidil | |
| FR2802096A1 (fr) | Composition, notamment cosmetique, comprenant un acide triterpene pentacyclique | |
| FR2857222A1 (fr) | Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique | |
| FR2543828A1 (fr) | Nouvelle composition anti-acneique a base de tioxolone et d'au moins un autre principe actif | |
| BE1000153A4 (fr) | Composition anti-acneique stable a base d'erythromycine. | |
| FR2569561A1 (fr) | Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone | |
| EP0671164A1 (fr) | Compositon pour lutter contre les taches et/ou vieillissement de la peau, ses utilisations | |
| EP0753341A1 (fr) | Utilisation de composés hydrofluocarbonés à fonction thioester dans des émulsions, applications cosmétiques ou dermatologiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: S.A. L OREAL Effective date: 19921231 |